These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3862890)

  • 21. [Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213].
    Amiel JL; Schwarzenberg L; Musset M; De Vassal F; Hayat M; Mathé G
    Bull Cancer; 1974; 61(3):419-26. PubMed ID: 4533742
    [No Abstract]   [Full Text] [Related]  

  • 22. [Petechiae, suffusions and cytarabine-induced erythema in treatment of acute myeloid leukemia].
    Taverna C; Jacky E; Sauter C
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1117. PubMed ID: 9691347
    [No Abstract]   [Full Text] [Related]  

  • 23. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.
    Patton T; Zirwas M; Nieland-Fisher N; Jukic D
    J Drugs Dermatol; 2004; 3(5):565-6. PubMed ID: 15552612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contact dermatitis due to sensitization to lactic acid and castor oil in a wart remover solution.
    Tabar AI; Muro MD; Quirce S; Olaguibel JM
    Contact Dermatitis; 1993 Jul; 29(1):49-50. PubMed ID: 8365163
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia.
    Saito B; Nakamaki T; Nakashima H; Usui T; Hattori N; Kawakami K; Tomoyasu S
    Am J Hematol; 2007 Apr; 82(4):304-6. PubMed ID: 16947320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperleukocytosis from arsenic trioxide.
    Levy M; Wofford MM; Powell BL; McLean TW
    Pediatr Blood Cancer; 2008 Jun; 50(6):1265-7. PubMed ID: 18300308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New agents in the treatment of leukemia and lymphoma].
    Yamada K
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1031-40. PubMed ID: 6347079
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of acute myeloid leukemia with an intense chemotherapeutic regimen and variable reduction of the dosage for elderly patients].
    Whittaker JA
    Clin Ter; 1982 Sep; 102(5):435-41. PubMed ID: 6960975
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug-induced hypersensitivity syndrome with rapid hematopoietic reconstitution during treatment for acute myeloid leukemia.
    Suzuki HI; Asai T; Tamaki Z; Hangaishi A; Chiba S; Kurokawa M
    Haematologica; 2008 Mar; 93(3):469-70. PubMed ID: 18310542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytarabine.
    Med Lett Drugs Ther; 1971 Jan; 13(1):3-4. PubMed ID: 5284023
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of acute leukemia with newly synthesized N4-behenoyl-l-beta-D-arabinofuranosylcytosine (BH-AC) (author's transl)].
    Sueyama H; Oguro M; Takagi T
    Rinsho Ketsueki; 1981 Jul; 22(7):1109-15. PubMed ID: 7328768
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of leukemia in children].
    Seip M
    Tidsskr Nor Laegeforen; 1974 Jan; 94(3):167-71. PubMed ID: 4522750
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.
    Gradishar WJ; Tjulandin S; Davidson N; Shaw H; Desai N; Bhar P; Hawkins M; O'Shaughnessy J
    J Clin Oncol; 2005 Nov; 23(31):7794-803. PubMed ID: 16172456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytarabine-induced neurotoxicity responding to methyl prednisolone.
    Malhotra P; Mahi S; Lal V; Kumari S; Jain S; Varma S
    Am J Hematol; 2004 Dec; 77(4):416. PubMed ID: 15551283
    [No Abstract]   [Full Text] [Related]  

  • 36. [G-CSF and all-trans retinoic acid-induced leukocytosis].
    Wu W; Sun G; Wu W
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):273-5. PubMed ID: 9387319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
    Miyawaki S; Mizoguchi H; Tomonaga M; Kanamaru A; Tsukagoshi S; Nakamura T; Ohashi Y; Yoshida S; Ohno R
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2229-42. PubMed ID: 9881080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia.
    Sommer C; Lackner H; Benesch M; Sovinz P; Schwinger W; Moser A; Bergloeff J; Gruber A; Urban C
    Ann Hematol; 2008 Nov; 87(11):887-90. PubMed ID: 18575860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
    Watanabe A; Kuriyama H; Kiyota T
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):291-6. PubMed ID: 8712821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen therapy during myeloblastic leukemia remission induced by two drug combinations.
    Pavlovsky S; Scaglione C; Eppinger-Helft M; Muriel FS; Macchi A; Garay G; Cavagnaro F; Birman V; Dupont J; Suarez A; Dragosky MO; Barros CA
    Medicina (B Aires); 1981; 41(1):11-8. PubMed ID: 7022104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.